ATYR: aTyr Pharma, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
aTyr Pharma, Inc. (ATYR) uchun narx-foyda va foyda o'sishi koeffitsiyenti dinamikasi yuqori tadqiqot xarajatlari tufayli marjaning stagnatsiyasini tasdiqlaydi. 0.00 belgisi o'pka fibrozisiga qarshi immunoterapiyani ishlab chiqayotgan aktivning joriy holatini aks ettiradi. Tijorat sotuvlarining yo'qligi va sinovlarga doimiy kapital xarajatlar kompaniya klinik sinovlar bosqichida qolgan holda foyda generatsiyasiga to'sqinlik qilmoqda.
aTyr Pharma, Inc. (ATYR) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati aTyr Pharma, Inc.|ATYR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi atyrpharma.com|ATYR - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar aTyr|ATYR - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari aTyr Pharma|Oraliq likvidlik koeffitsiyenti atyrpharma.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ATYR - Sof daromad|Kutilayotgan sof foyda aTyr Pharma, Inc.|ATYR - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori aTyr Pharmaceuticals|ATYR - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati aTyr|ATYR - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda aTyr Pharma|ATYR - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi atyrpharma.com|ATYR - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi aTyr Pharma, Inc.
Kompaniyaning umumiy tahlili:ATYR - aTyr Pharma Inc
Fundamental xatarlarni minimallashtirish uchun investorlar baholash va daromadlar o'sishining optimal muvozanatiga ega aktivlarni tanlaydilar. Ushbu metrika P/E koeffitsientini o'sish sur'atlariga moslashtirib, spekulyativ buzilishlarsiz kapital qiymati oshishining real qiymatini aniqlaydi. Bioteknologiya sektori va aTyr Pharma, Inc. (ATYR) uchun bunday hisob-kitoblar ESG filtrlash xarajatlarini va laboratoriyalarning ekologik modernizatsiyasini hisobga oladi. Birga solishtirganda pastroq qiymatlar biznesning qadrsizlanganini anglatadi. aTyr Pharma, Inc. (ATYR) kompaniyasining joriy PEG baholashi "raketa" potensialini yoki operatsion pasayish xavfini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|ABCL (abcellera.com) - Narx-foyda va o‘sish multiplikatori|TRML: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori PGEN|O‘sish sur’atiga tuzatilgan narx-foyda Pharming Group NV PHAR|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Zenas Biopharma Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IMNM|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati KALV|SEPN: PEG multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc.) - PEG multiplikatori|PEG multiplikatori rigel.com|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT - Narx-foyda va o‘sish multiplikatori|Aerovate - PEG multiplikatori|ACRS - PEG multiplikatori|KYTX (Kyverna Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|Tiziana Life Sciences Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Theratechnologies Inc. (THTX)|avalotx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati zurabio.com ZURA|ADAG: PEG multiplikatori|Ikena Oncology (IMA) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori STTK|EQ (Equillium Bio) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CNTB (Connect Biopharma)|IMUX - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IFRX|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ACET|CELU: PEG multiplikatori|INmune Bio Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|PEG multiplikatori kezarlifesciences.com|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|IBIO (iBio) - Narx-foyda va o‘sish multiplikatori|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|Bolt Bio (BOLT) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI: Narx-foyda va o‘sish multiplikatori|XRTX - PEG multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti REVB|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Scinai Immunotherapeutics Ltd SCNI|PEG multiplikatori CALI|PEG multiplikatori affimed.com (AFMD)|Allakos - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati HOOK (HOOKIPA Pharma, Inc.)|IGMS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori THRD
